Title

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

UMMS Affiliation

Department of Medicine, Division of Dermatology; Department of Quantitative Health Sciences

Date

1-1-2017

Document Type

Letter to the Editor

Disciplines

Dermatology | Skin and Connective Tissue Diseases | Translational Medical Research

Abstract

We conducted a small, randomized, double-blind, placebo-controlled, phase II clinical trial to test simvastatin as a treatment for vitiligo.

Rights and Permissions

Citation: J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. Link to article on publisher's site

Related Resources

Link to Article in PubMed

Keywords

UMCCTS funding

PubMed ID

27986135